specialized in Brand Strategy Planning, Customer Experience Management and Digital Marketing I&I Experience Company Limited (the subsidiary) was established on June 25, 2019. The main business is to provide

with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000

continued to grow at 25% YoY. This was impacted by financial statement adjustment in accordance with new Thai accounting standards. According to the previous accounting standards, Q3/2019 total sales would

to grow at 3% YoY from sales recognition of new and some existing products. This was impacted by financial statement adjustment in accordance with new Thai accounting standards. According to the

Company and its subsidiaries recorded total sales of Baht 1,174 million, a decrease of 19% YoY, occurred from a decline in domestic branded sales and impacted from financial statement adjustment in

to Baht 39.21 million, which increased by Baht 12.66 million, or 48%,. The main cause was more commission income in of 2018, which increased by Baht 13.40 million. 1.4 Operational profit and net profit

year 2019 increased 51.20 and 61.28 percent from the same period of last year. Main attribution is increasing in sales quantities from 2nd production line. The effect from Thai Baht appreciation and

had been audited by the independent auditor. Details are as follows: 1. Main events of the Company 2. Summary of the Company’s operating results 3. Analysis of the consolidated financial performance 4

Exchange of Thailand. Demco Public Company Limited would like to inform you herewith the company result of the 2nd quaternary for the year 2017 according to the company’s financial statement ended June 30

recognized on the basis of impairment loss on investments amounting to 46.92 million baht and valuation of impairment loss on general investments amounting to 0.84 million baht. The consolidated statement